Safety and Efficacy of Hepatitis B Vaccination in Cirrhosis of Liver by D. Ajith Roni, Rama Mohan Pathapati, A. Sathish Kumar, Lalit Nihal, K. Sridhar, Sujith Tumkur Rajashekar

“…We observed that the alcoholic chronic liver disease had less antibody response (44%) than other causes of chronic liver disease such as cryptogenic 69% and HCV 75%. …”
Get full text

The Impact of Interferon Lambda 3 Gene Polymorphism on Natural Course and Treatment of Hepatitis C by F. Bellanti, G. Vendemiale, E. Altomare, G. Serviddio

Get full text

Noninvasive Predictors of High-Risk Varices in Patients with Non-Cirrhotic Portal Hypertension by Morven E. Cunningham, Gilda Parastandeh-Chehr, Orlando Cerocchi, David K. Wong, Keyur Patel

Get full text

Hepatocellular Carcinoma in a 24-Year-Old Female with Beckwith–Wiedemann Syndrome: A Case Report and Review of the Literature by Carolyn G. Ahlers, Quoc-Huy Trinh, Martin Montenovo

“…Although HCC typically occurs in elderly adults or those with underlying liver disease, in this case, we show that HCC can occur in a young adult with BWS without any underlying liver disease.…”
Get full text

Role of NKT Cells in the Pathogenesis of NAFLD by Kazuto Tajiri, Yukihiro Shimizu

“…Nonalcoholic fatty liver disease (NAFLD) is the most frequent chronic liver disease and shows various inflammatory changes in the liver. …”
Get full text

Recent advances in polymeric nanoparticles for the treatment of hepatic diseases by Feng Gao, Xuefei Feng, Xinyu Li

“…Compared to traditional therapies, they offer significant advantages in the treatment of liver disease by improving outcomes and reducing side effects. …”
Get full text

Case of acute drug-induced hepatitis after halothane anesthesia by I. Yu. Pirogova, Ye. V. Berestova, O. Yu. Bastrikov, Ye. B. Kovaleva, T. P. Petukhova, M. V. Guseva, I. A. Gubina, I. V. Rezepin, S. P. Sinitsyn

“…The most important factors determining favorable prognosis at drug-induced liver disease, include adequate doses of glucocorticosteroids, application of MARS-therapy and absence of background liver disease. …”
Get full text

Investigation of the healing effects of Afyon Province hot spring waters on experimentally-induced fatty liver in mice by Bülent Elitok, Ibrahim Kişlalioğlu, Yavuz Ulusoy, Bahadır Kilinç

“…Due the increasing number of alcoholic fatty liver disease cases in the world, the development of methods for treating this disease is an urgent task. …”
Get full text

Impact of underlying diseases and complications on COVID-19 mortality in South Korea: analysis of national health insurance service data by Kyunghee Lee, Jieun Hwang

“…Except for liver disease, all underlying diseases were associated with mortality. …”
Get full text

Serum Endocan as a Survival Predictor for Patients with Liver Cirrhosis by Nobuyuki Toshikuni, Kazuaki Ozaki, Joseph George, Mikihiro Tsutsumi

“…BACKGROUND: The relationship between endocan expression and outcome in patients with chronic liver disease is not fully understood.…”
Get full text

Drug Advances in NAFLD: Individual and Combination Treatment Strategies of Natural Products and Small-Synthetic-Molecule Drugs by Xing Wan, Jingyuan Ma, He Bai, Xuyang Hu, Yanna Ma, Mingjian Zhao, Jifeng Liu, Zhijun Duan

“…Non-alcoholic fatty liver disease (NAFLD) has become the most common chronic liver disease and is closely associated with metabolic diseases such as obesity, type 2 diabetes mellitus (T2DM), and metabolic syndrome. …”
Get full text

Penyeimbangan Kelas SMOTE dan Seleksi Fitur Ensemble Filter pada Support Vector Machine untuk Klasifikasi Penyakit Liver by Muhammad Amir Nugraha, Muhammad Itqan Mazdadi, Andi Farmadi, Muliadi, Triando Hamonangan Saragih

“…Classification of liver disease in patients needs to be done well because the results can help in the initial diagnosis of whether a patient has liver disease. …”
Get full text

Wilson’s Disease and Autoimmune Hepatitis Coexistence: A Cause of Diagnostic Delay by Mohammed G Mudawi, Salma Barakat MD, Elhadi M Awooda

“…Wilson’s disease, although rare, should be suspected in patients with decompensated liver disease. The dominance of clinical and epidemiological features of autoimmune hepatitis as a common causative pathology for chronic liver disease in young and middle-aged ladies may hide the presence of other serious different pathologies such as Wilson’s disease. …”
Get full text

Efficacy and Safety of a Novel Pegylated Interferon Alpha-2a in Egyptian Patients with Genotype 4 Chronic Hepatitis C by Alaa Awad Taha, Ahmad El-Ray, Maged El-Ghannam, Bahaa Mounir

“…BACKGROUND: Hepatitis C virus (HCV) genotype 4 is a common infection in Egypt and is the leading cause of liver disease.…”
Get full text

The Feasibility and Reliability of Transient Elastography Using Fibroscan®: A Practice Audit of 2335 Examinations by Jack XQ Pang, Faruq Pradhan, Scott Zimmer, Sophia Niu, Pam Crotty, Jenna Tracey, Christopher Schneider, Steven J Heitman, Gilaad G Kaplan, Mark G Swain, Robert P Myers

“…BACKGROUND: Liver stiffness measurement (LSM) using transient elastography is widely used in the management of patients with chronic liver disease.…”
Get full text

Gambaran Profil Lipid Pasien Perlemakan Hati Non-Alkoholik by Vanny Syafitri, Arnelis ., Efrida .

“…<p>Abstrak<br />Penyakit perlemakan hati non-alkoholik (non-alcoholic fatty liver disease) merupakan kondisi klinis yang sering ditemukan dalam bidang hepatologi. …”
Get full text

Probiotics for Alleviating Alcoholic Liver Injury by Zelin Gu, Yanlong Liu, Shumeng Hu, Ying You, Jiaqi Wen, Wancong Li, Yuhua Wang

“…In this review, we summarize the current knowledge regarding the mechanism of action of probiotics for reducing the effects of alcoholic liver disease.…”
Get full text

The Use of Antibiotics for the Prophylaxis of Spontaneous Bacterial Peritonitis: A Retrospective Review and Quality Improvement Study by Ariana Tagliaferri, Nida Ansari, Gabriel Melki, Yana Cavanagh

“…Conclusion: We intend to educate providers on the appropriate time to intervene to reduce mortality and subsequent hospitalizations for those with advanced liver disease.…”
Get full text

Multiple Bone Metastases as the First Manifestation of Hepatocellular Carcinoma in Patient with Noncirrhotic Liver by Soo Ya Bae, Hyun Jung Kim, Hyun Ho Oh, Min Kwan Kwon, Jong Ho Lee, Moon Park, Byeong Seok Sohn

“…Hepatocellular carcinoma (HCC) generally occurs on the background of chronic liver disease. Chronic hepatitides B and C and alcoholic liver disease are well-known risk factors for HCC, and it is uncommon in noncirrhotic liver. …”
Get full text

Rationale and Design of RNAFH Study: Effect of Rosuvastatin (10 mg/d) on Nonalcoholic Fatty Liver in Metabolic Syndrome Patients without Overt Diabetes Evaluated by 1H-Magnetic Res... by Fan Ping, Xuan Wang, Jing Yang, Mei-cen Zhou, Wei Li, Ling-ling Xu, Yu-xiu Li

“…The RNAFH study (effect of rosuvastatin on nonalcoholic fatty liver disease in metabolic syndrome patients without overt diabetes evaluated by 1H-MRS) is a prospective randomized, single-center, open-label trail designed to assess the effect of rosuvastatin on the intrahepatocellular lipid (IHCL) level of nonalcoholic fatty liver disease (NAFLD). …”
Get full text